Tonix Pharmaceuticals is currently enrolling participants in a Phase 3 trial for posttraumatic stress disorder (PTSD). For more information, please visit www.recoverystudy.com or www.clinicaltrials.gov (NCT03841773).

News & Events

: Tonix In The News

Home
News & Events
Tonix In The News

Tonix In The News

The Big Leap from Academic to Entrepreneur

The Medicine Maker |

May 5, 2015

Better Sleep, Less Pain: Studying the Links

Clinical Pain Advisor |

March 26, 2015

Long battles remain for veterans suffering from PTSD

Daily News |

November 11, 2014

A ‘Second Revolution’ in Drug Discovery and Development

DDD Magazine |

August 27, 2014

The Evolving Role Of Drug Mechanism Of Action In Drug Discovery And Development

Life Science Leader |

July 1, 2014

Interview with Dr. Seth Lederman CEO of Tonix Pharmaceuticals

Fibro & Fabulous |

June 23, 2014

Tonix Pharmaceuticals developing treatment for underserved PTSD patients

MedCity News |

June 23, 2014

Tonix Gets IND Clearance from FDA for PTSD Treatment

Drug Delivery & Development |

June 11, 2014

Tonix receives IND approval for sublingual formulation to treat PTSD

Fierce Drug Delivery |

June 10, 2014

Tonix's sublingual formulation for fibromyalgia reaches pivotal trial stage